For Palo Alto, California residents, geographic distance from mainland pharmacies has historically affected access to specialty medications. Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk; Pacific-region retail pricing varies by pharmacy. Weight Method offers a separate telehealth program: licensed California providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program is priced at $199/month uniformly, shipped directly to your Palo Alto address.
FDA-approved Wegovy prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Palo Alto is already seeing results
Wegovy in Palo Alto, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Wegovy to patients in Palo Alto from $199/month with virtual consultations and direct-to-door shipping.
For many people in Palo Alto, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide addresses hormonal drivers involved in body weight regulation. Wegovy® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk, approved in 2021 for Chronic weight management. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The program is priced at $199/month, including the evaluation, the medication, ongoing care, and home delivery to Palo Alto.
Research suggests Semaglutide therapy is studied across diverse populations, and outcomes can improve when care is culturally informed. In Palo Alto, Weight Method pairs compounded Semaglutide treatment (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved) with bilingual support that respects cultural context, from dietary guidance that accounts for traditional foods to communication in the language you are most comfortable with. The program starts at $199/month.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Wegovy from $199/month.
Get Started NowFree consultation. No commitment.